Lynch & Associates Medtronic PLC Transaction History
Lynch & Associates
- $429 Million
- Q1 2024
A detailed history of Lynch & Associates transactions in Medtronic PLC stock. As of the latest transaction made, Lynch & Associates holds 4,739 shares of MDT stock, worth $367,793. This represents 0.1% of its overall portfolio holdings.
Number of Shares
4,739Holding current value
$367,793% of portfolio
0.1%Shares
1 transactions
Others Institutions Holding MDT
# of Institutions
2,240Shares Held
1.05BCall Options Held
6.1MPut Options Held
7.84M-
Vanguard Group Inc Valley Forge, PA126MShares$9.8 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY114MShares$8.85 Billion0.23% of portfolio
-
State Street Corp Boston, MA60.1MShares$4.66 Billion0.24% of portfolio
-
Jpmorgan Chase & CO New York, NY31.6MShares$2.45 Billion0.25% of portfolio
-
Capital Research Global Investors Los Angeles, CA30.9MShares$2.4 Billion0.63% of portfolio
About Medtronic plc
- Ticker MDT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,329,149,952
- Market Cap $103B
- Description
- Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...